BJRI
Price
$57.15Alerts
Change
+$1.56 (+2.81%)
Updated
Nov 11 closing price
Capitalization
1.18B
99 days until earnings call
Intraday BUY SELL Signals
GENK
Price
$1.03Alerts
Change
-$0.48 (-31.79%)
Updated
Nov 11 closing price
Capitalization
6.81M
Intraday BUY SELL Signals
Interact to see
Advertisement

BJRI vs GENK

BJRI vs GENK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BJRI vs. GENK commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BJRI is a Hold and GENK is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BJRI with price predictions
Nov 10, 2026

Momentum Indicator for BJRI turns negative, indicating new downward trend

BJRI saw its Momentum Indicator move below the 0 level on November 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In 65 of the 87 cases, the stock moved further down in the following days. The odds of a decline are at 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BJRI turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 34 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

BJRI moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BJRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

BJRI broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BJRI entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for BJRI crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +10.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where BJRI advanced for three days, in 227 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. BJRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.980) is normal, around the industry mean (-0.877). P/E Ratio (28.549) is within average values for comparable stocks, (18.791). Projected Growth (PEG Ratio) (1.655) is also within normal values, averaging (7.754). Dividend Yield (0.009) settles around the average of (0.049) among similar stocks. P/S Ratio (0.916) is also within normal values, averaging (2.618).

The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for GENK with price predictions
Nov 10, 2026

GENK sees its Stochastic Oscillator recovers from oversold territory

On November 10, 2026, the Stochastic Oscillator for GENK moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 44 instances where the indicator left the oversold zone. In 39 of the 44 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GENK's RSI Oscillator exited the oversold zone, 23 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

Following a +18.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where GENK advanced for three days, in 124 of 153 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

GENK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GENK as a result. In 46 of 50 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for GENK turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 34 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GENK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.423) is normal, around the industry mean (-0.877). P/E Ratio (-1.512) is within average values for comparable stocks, (18.791). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (7.754). Dividend Yield (0.094) settles around the average of (0.049) among similar stocks. P/S Ratio (0.040) is also within normal values, averaging (2.618).

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. GENK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GENK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
BJRI: Fundamental Ratings
BJRI
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
68
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
35
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BJRIGENK
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
72%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BJRI: $55.59 vs. GENK: $1.51)
Brand notoriety: BJRI and GENK are both not notable
Both companies represent the Restaurants industry
Current volume relative to the 65-day Moving Average: BJRI: 92% vs. GENK: 6%
Market capitalization -- BJRI: $1.18B vs. GENK: $6.81M
BJRI [@Restaurants] is valued at $1.18B. GENK’s [@Restaurants] market capitalization is $6.81M. The market cap for tickers in the [@Restaurants] industry ranges from $1.6K to $195.68B. The average market capitalization across the [@Restaurants] industry is $10.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BJRI’s FA Score shows that 0 FA rating(s) are green while GENK’s FA Score has 2 green FA rating(s).

  • BJRI’s FA Score: 0 green, 5 red.
  • GENK’s FA Score: 2 green, 3 red.
According to our system of comparison, BJRI is a better buy in the long-term than GENK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BJRI’s TA Score shows that 3 TA indicator(s) are bullish while GENK’s TA Score has 4 bullish TA indicator(s).

  • BJRI’s TA Score: 3 bullish, 6 bearish.
  • GENK’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GENK is a better buy in the short-term than BJRI.

Price Growth

BJRI (@Restaurants) experienced а -8.30% price change this week, while GENK (@Restaurants) price change was +8.63% for the same time period.

The average weekly price growth across all stocks in the @Restaurants industry was -6.24%. For the same industry, the average monthly price growth was +4.11%, and the average quarterly price growth was +9.31%.

Reported Earning Dates

BJRI is expected to report earnings on Feb 18, 2027.

Industries' Descriptions

@Restaurants (-6.24% weekly)

The industry includes companies that operate full-service restaurants, fast food restaurants, cafeterias and snack bars. McDonald`s Corporation, Starbucks Corporation, YUM! Brands, Inc. and Restaurant Brands International Inc. are some of the largest U.S. restaurant-owning companies in terms of market capitalization. While restaurant spending could be viewed as discretionary for consumers, some companies in the business have been able to weather economic cycles by establishing strong loyalty among customers over the years. Many of them also have a strong global presence as well.

View a ticker or compare two or three
Interact to see
Advertisement

BJRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BJRI has been loosely correlated with CAKE. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if BJRI jumps, then CAKE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BJRI
1D Price
Change %
BJRI100%
-3.67%
CAKE - BJRI
62%
Loosely correlated
-1.68%
TXRH - BJRI
53%
Loosely correlated
-1.24%
FWRG - BJRI
53%
Loosely correlated
-2.96%
CBRL - BJRI
52%
Loosely correlated
-2.75%
BLMN - BJRI
52%
Loosely correlated
-3.40%
More

GENK and

Correlation & Price change

A.I.dvisor tells us that GENK and BLMN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENK and BLMN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENK
1D Price
Change %
GENK100%
+6.34%
BLMN - GENK
31%
Poorly correlated
-3.40%
ARCO - GENK
25%
Poorly correlated
-2.69%
SBUX - GENK
23%
Poorly correlated
+0.47%
DIN - GENK
23%
Poorly correlated
-1.24%
BJRI - GENK
23%
Poorly correlated
-3.67%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMP519.961.66
+0.32%
Ameriprise Financial
SFBS41.50-0.18
-0.43%
Servisfirst Bancshares Inc
APOG47.83-0.22
-0.46%
Apogee Enterprises
BIRD1.26-0.09
-6.67%
Smartbird Inc
ADCT1.51-0.16
-9.58%
ADC Therapeutics SA